News

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for CardioTag, Cardiosense’s multimodal, wearable ...
The new wearable technology can assess multiple cardiovascular metrics, including electrical impulses and blood flow, to alert patients and clinicians to worsening heart failure and other conditions.
Chicago-based Cardiosense has received 510(k) clearance from the FDA for its CardioTag device, a multimodal wearable sensor.  The CardioTag is designed to provide clinicians with a comprehensive, ...
The FDA has granted clearance for the CardioTag device to assess cardiac function and improve patient outcomes across various healthcare settings.
The American Heart Association gave $5.5 million to the University of Michigan for research to improve the screening and treatment of heart disease.
Learn what asset tracking is, how it works, its benefits, types and how to choose the right one for your business.